Get the Stockscreener App
1.40
0.00%
0.02
Biocardia Inc stock is traded at $1.40, with a volume of 418.22K.
It is up +0.00% in the last 24 hours and down -28.17% over the past month.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
See More
Previous Close:
$1.42
Open:
$1.44
24h Volume:
418.22K
Relative Volume:
0.59
Market Cap:
$8.13M
Revenue:
$468.00K
Net Income/Loss:
$-10.34M
P/E Ratio:
-0.1986
EPS:
-7.05
Net Cash Flow:
$-8.94M
1W Performance:
+27.93%
1M Performance:
-28.17%
6M Performance:
-49.29%
1Y Performance:
-51.70%
1-Day Range:
$1.38
$1.44
1-Week Range:
$1.17
$1.50
52-Week Range:
$1.00
$3.20
Biocardia Inc Stock (BCDA) Company Profile
Name
Biocardia Inc
Sector
Industry
Phone
650-226-0123
Address
320 SOQUEL WAY, SUNNYVALE, CA
Compare BCDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
4.66 | 6.63B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.39 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.10 | 141.22M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2725 | 610.36M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.185 | 0 | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-16-21 | Downgrade | Dawson James | Buy → Neutral |
Biocardia Inc Stock (BCDA) Latest News
Will BioCardia Inc. stock attract ESG investors2025 Technical Overview & Accurate Intraday Trade Tips - newser.com
Using data models to predict BioCardia Inc. stock movementJuly 2025 Drop Watch & AI Powered Market Entry Strategies - newser.com
Trend analysis for BioCardia Inc. this weekJuly 2025 Big Picture & Growth-Oriented Investment Plans - newser.com
BioCardia Inc. stock chart pattern explainedGap Up & Free Fast Entry Momentum Trade Alerts - newser.com
Ranking BioCardia Inc. among high performing stocks via toolsQuarterly Earnings Summary & Daily Technical Forecast Reports - newser.com
What analysts say about BioCardia Inc stockMACD Histogram Signals & Budget Friendly Portfolio - earlytimes.in
Will BioCardia Inc. benefit from macro trendsWeekly Trading Summary & Stock Portfolio Risk Control - newser.com
Top chart patterns to watch in BioCardia Inc.Portfolio Value Summary & Expert Approved Momentum Ideas - newser.com
Is BioCardia Inc 6JU0 a good long term investmentTrading Volume Trends & Market Volatility Strategies - earlytimes.in
BioCardia Inc. (BCDA) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
What high frequency data says about BioCardia Inc.July 2025 Action & Fast Momentum Stock Entry Tips - newser.com
How BioCardia Inc. (6JU0) stock reacts to weak economyJuly 2025 Earnings & Consistent Growth Equity Picks - newser.com
Is BioCardia Inc a good long term investmentDividend Stability Analysis & High-Risk, High-Reward? We Find the Winners - Early Times
BioCardia Executives Make Bold Moves with Major Stock Purchases - TipRanks
BioCardia stock maintains Buy rating at H.C. Wainwright on positive trial data - Investing.com Canada
Biocardia director Stertzer buys $498k in shares - Investing.com India
Altman Peter, president and CEO of BioCardia, buys $60000 in BCDA - Investing.com India
Biocardia director Blank buys $360k in common stock By Investing.com - Investing.com Australia
Altman Peter, president and CEO of BioCardia, buys $60000 in BCDA By Investing.com - Investing.com South Africa
Biocardia director Stertzer buys $498k in shares By Investing.com - Investing.com South Africa
Biocardia director Blank buys $360k in common stock - Investing.com India
Insider Buying: Peter Altman Acquires 48,000 Shares of BioCardia Inc (BCDA) - GuruFocus
Biocardia Insider Bought Shares Worth $360,000, According to a Recent SEC Filing - MarketScreener
Biocardia Insider Bought Shares Worth $498,000, According to a Recent SEC Filing - MarketScreener
BioCardia holds positive preliminary consultation with Japan’s PMDA By Investing.com - Investing.com Nigeria
BioCardia’s Positive Consultation with Japan’s PMDA - MSN
What’s next for BioCardia Inc. stock priceJuly 2025 Reactions & High Conviction Investment Ideas - newser.com
BioCardia holds positive preliminary consultation with Japan’s PMDA - Investing.com India
BioCardia (BCDA): Analyst Maintains Buy Rating and Price Target - GuruFocus
Analyzing drawdowns of BioCardia Inc. with statistical tools2025 Year in Review & Reliable Entry Point Trade Alerts - newser.com
Heatmap analysis for BioCardia Inc. and competitorsEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
BioCardia (BCDA) Prepares for Formal Consultation with Japan's P - GuruFocus
Biocardia Inc Stock (BCDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Biocardia Inc Stock (BCDA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Blank Andrew Scott | Director |
Sep 19 '25 |
Buy |
1.25 |
288,000 |
360,000 |
634,023 |
| Altman Peter | President and CEO |
Sep 19 '25 |
Buy |
1.25 |
48,000 |
60,000 |
216,762 |
| Altman Peter | President and CEO |
Aug 22 '25 |
Buy |
1.83 |
700 |
1,281 |
168,762 |
| Altman Peter | President and CEO |
Aug 13 '25 |
Buy |
1.83 |
100 |
183 |
168,062 |
| Altman Peter | President and CEO |
Aug 12 '25 |
Buy |
1.75 |
400 |
700 |
167,962 |
| Altman Peter | President and CEO |
Aug 11 '25 |
Buy |
1.76 |
1,700 |
2,989 |
167,562 |
| McClung David | Chief Financial Officer |
Jun 30 '25 |
Buy |
2.08 |
4,819 |
9,999 |
47,950 |
| Altman Peter | President and CEO |
Jun 30 '25 |
Buy |
2.08 |
24,096 |
49,999 |
165,862 |
| STERTZER SIMON H | Director |
Jun 30 '25 |
Buy |
2.08 |
72,289 |
150,000 |
192,654 |
| Blank Andrew Scott | Director |
Jun 30 '25 |
Buy |
2.08 |
72,289 |
150,000 |
346,023 |
0.98%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):